Glenview Trust’s CME Group CME Stock Holding History

Glenview Trust’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$366K	Buy	1,238 +294	+31%	+$87.3K	0.01%	409
2025 Q4	$258K	Buy	+944	New	+$257K	﹤0.01%	448

Other funds holding CME

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Glenview Trust's CME Position: Q1 2026 in Review

Glenview Trust increased its CME Group (CME) stake by 31% in Q1 2026, buying an estimated $87.3K and bringing the position to 1,238 shares worth $366K. The position accounts for 0.01% of the portfolio, ranked #409.

Glenview Trust first reported a position in CME in Q4 2025 and has held it in 2 quarters since. 1,790 funds tracked by Wall St. Rank hold CME as of Q1 2026.

Glenview Trust held 1,238 shares of CME Group worth $366K as of Q1 2026.
Glenview Trust bought 294 CME Group shares in Q1 2026, an estimated $87.3K.
CME Group made up 0.01% of Glenview Trust's portfolio in Q1 2026, its #409 holding.
Glenview Trust first reported a position in CME Group in Q4 2025 and has held it in 2 quarters since.
1,790 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on Glenview Trust's 13F filing for Q1 2026, filed 8 May 2026.